In the News story ‘Doubts over heart stem-cell therapy’ (Nature 509, 15–16; 2014), the low-oxygen method for preparing mesenchymal stem cells was erroneously attributed to a Moscow research institute. The Moscow institute developed the experimental concept, but the low-oxygen refinement was developed in the United States. Mention of the institute has therefore been removed online.